1. Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome
- Author
-
Jun Hee Woo, Seongman Bae, Yang Soo Kim, Sang-Oh Lee, Sang-Ho Choi, Sung-Han Kim, Min Jae Kim, Mi Young Kim, Yong Pil Chong, and Hye Jeon Hwang
- Subjects
0301 basic medicine ,Microbiology (medical) ,Antifungal ,medicine.medical_specialty ,Aspergillosis invasive pulmonary ,Antifungal Agents ,Fever ,Severe Fever with Thrombocytopenia Syndrome ,medicine.drug_class ,030106 microbiology ,law.invention ,SFTS bunyavirus ,03 medical and health sciences ,law ,Internal medicine ,medicine ,Humans ,In patient ,skin and connective tissue diseases ,Retrospective Studies ,Invasive Pulmonary Aspergillosis ,business.industry ,Invasive pulmonary aspergillosis ,bacterial infections and mycoses ,medicine.disease ,Intensive care unit ,Thrombocytopenia ,respiratory tract diseases ,Severe fever with thrombocytopenia syndrome ,Intensive Care Units ,030104 developmental biology ,Infectious Diseases ,business ,Severe fever with thrombocytopenia syndrome virus - Abstract
Sixteen of 45 patients with severe fever with thrombocytopenia (36%) were admitted to an intensive care unit; 9 (56%) developed invasive pulmonary aspergillosis (IPA) within a median of 8 days (range, 2–11). Mortality was higher in the IPA vs non-IPA patients and in those without vs with antifungal therapy.
- Published
- 2019